These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24326901)

  • 1. Comorbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation.
    Noteboom B; Jenkins S; Maiorana A; Cecins N; Ng C; Hill K
    J Cardiopulm Rehabil Prev; 2014; 34(1):75-9. PubMed ID: 24326901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of referral to and attendance at a pulmonary rehabilitation programme amongst patients admitted to a tertiary hospital with chronic obstructive pulmonary disease.
    Johnston K; Young M; Grimmer K; Antic R; Frith P
    Respirology; 2013 Oct; 18(7):1089-94. PubMed ID: 23711304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity associated with referral to pulmonary rehabilitation in people hospitalized with chronic obstructive pulmonary disease.
    Li LS; Caughey G; Johnston K
    J Cardiopulm Rehabil Prev; 2014; 34(6):430-6. PubMed ID: 25166258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medication use for primary care patients with and without medical comorbidities: a national electronic health record (EHR) network study.
    Gill JM; Klinkman MS; Chen YX
    J Am Board Fam Med; 2010; 23(4):499-508. PubMed ID: 20616292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.
    Crisafulli E; Costi S; Luppi F; Cirelli G; Cilione C; Coletti O; Fabbri LM; Clini EM
    Thorax; 2008 Jun; 63(6):487-92. PubMed ID: 18203818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
    Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patients.
    Solem CT; Lee TA; Joo MJ; Lambert BL; Walton SM; Pickard AS
    Am J Geriatr Pharmacother; 2012 Apr; 10(2):110-122.e1. PubMed ID: 22280978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of pulmonary rehabilitation in New Zealand by people with chronic obstructive pulmonary disease in 2009.
    Levack WM; Weatherall M; Reeve JC; Mans C; Mauro A
    N Z Med J; 2012 Jan; 125(1348):23-33. PubMed ID: 22282274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease.
    Carreiro A; Santos J; Rodrigues F
    Rev Port Pneumol; 2013; 19(3):106-13. PubMed ID: 23664247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
    Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
    Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of chronic obstructive pulmonary disease exacerbation on pulmonary rehabilitation participation and functional outcomes.
    Steele BG; Belza B; Cain K; Coppersmith J; Howard J; Lakshminarayan S; Haselkorn J
    J Cardiopulm Rehabil Prev; 2010; 30(1):53-60. PubMed ID: 20068424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.
    Roberts MH; Mapel DW; Hartry A; Von Worley A; Thomson H
    Ann Am Thorac Soc; 2013 Aug; 10(4):290-8. PubMed ID: 23952846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities of chronic obstructive pulmonary disease.
    Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of chronic obstructive pulmonary disease in the elderly population.
    Kobayashi S; Yanai M; Hanagama M; Yamanda S
    Respir Investig; 2014 Sep; 52(5):296-301. PubMed ID: 25169845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.